Published in Am J Pathol on February 01, 1973
Role of marrow-derived monocytes and mesangial cells in removal of immune complexes from renal glomeruli. J Exp Med (1979) 2.27
An overload hypothesis for pulmonary clearance of UICC amosite fibres inhaled by rats. Br J Ind Med (1983) 1.70
Incorporation of tritiated thymidine by epithelial and interstitial cells in bronchiolar-alveolar regions of asbestos-exposed rats. Am J Pathol (1989) 1.41
Radiation effects in the lung. Environ Health Perspect (1986) 1.29
Clonal growth of hamster free alveolar cells in soft agar. J Exp Med (1975) 1.14
The alveolar macrophage. Environ Health Perspect (1984) 0.95
Alterations in macrophage functions by environmental chemicals. Environ Health Perspect (1984) 0.88
Modeling in vitro cellular responses to silver nanoparticles. J Toxicol (2014) 0.78
Overview of pulmonary alveolar macrophage renewal in normal rats and during different pathological processes. Environ Health Perspect (1992) 0.78
Genotoxic changes in the pulmonary alveolar macrophages of mice, rats and hamsters treated with tobacco smoke. J Cancer Res Clin Oncol (1997) 0.75
Modelling the host-pathogen interactions of macrophages and Candida albicans using Game Theory and dynamic optimization. J R Soc Interface (2017) 0.75
THE ORIGIN OF MACROPHAGES FROM BONE MARROW IN THE RAT. Br J Exp Pathol (1965) 7.14
Mixed hematopoietic and pulmonary origin of 'alveolar macrophages' as demonstrated by chromosome markers. Am J Pathol (1966) 4.08
Hematopoietic origin of macrophages as studied by chromosome markers in mice. J Exp Med (1968) 2.97
Renewal of alveolar epithelium in the rat following exposure to NO2. Am J Pathol (1973) 2.80
Respiratory tissue: structure, histophysiology, cytodynamics. II. New approaches and interpretations. Int Rev Cytol (1964) 2.26
ALVEOLAR LINING CELLS AND PULMONARY RETICULOENDOTHELIAL SYSTEM OF THE RABBIT. Am J Pathol (1964) 1.62
Respiratory tissue: structure, histophysiology, cytodynamics. I. Review and basic cytomorphology. Int Rev Cytol (1964) 1.56
Early response of lungs to low levels of nitrogen dioxide. Light and electron microscopy. Arch Environ Health (1972) 1.44
Identification of cells labeled with tritiated thymidine in the pulmonary alveolar walls of the mouse. Am Rev Respir Dis (1969) 1.43
Evidence concerning the origin of liver macrophages. Br J Exp Pathol (1971) 1.28
Cell renewal in the lungs of rats exposed to low levels of NO2. Arch Environ Health (1972) 1.19
[RADIOAUTOGRAPHIC RESEARCH ON THE DURATION OF THE DNA SYNTHESIS PHASE IN MOUSE AND RAT CELLS BY DOUBLE LABELLING WITH H3- AND C-14-THYMIDINE]. Exp Cell Res (1965) 1.12
Establishment in culture of pluripotential cells from mouse embryos. Nature (1981) 30.49
Hemoglobin messenger ribonucleic acid. Synthesis of 9S and ribosomal ribonucleic acid during erythroid cell development. Biochemistry (1969) 5.37
Differentiation of clonal lines of teratocarcinoma cells: formation of embryoid bodies in vitro. Proc Natl Acad Sci U S A (1975) 4.95
Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med (1999) 4.81
The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development. Cell (1994) 4.58
Involvement of Brca2 in DNA repair. Mol Cell (1998) 4.41
Eomesodermin is required for mouse trophoblast development and mesoderm formation. Nature (2000) 3.53
The penetration of antibiotics into aggregates of mucoid and non-mucoid Pseudomonas aeruginosa. J Gen Microbiol (1989) 3.45
Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data. Lancet (2010) 3.21
Assignment of the membrane attachment, DNA binding, and transcriptional activation domains of sterol regulatory element-binding protein-1 (SREBP-1). J Biol Chem (1994) 3.09
Transformation of alveolar type 2 cells to type 1 cells following exposure to NO2. Exp Mol Pathol (1975) 3.07
B7, a B-cell-restricted antigen that identifies preactivated B cells. J Immunol (1987) 2.92
Renewal of alveolar epithelium in the rat following exposure to NO2. Am J Pathol (1973) 2.80
Priority given by doctors to continuity of care. J R Coll Gen Pract (1985) 2.74
Height and surfacing as risk factors for injury in falls from playground equipment: a case-control study. Inj Prev (1996) 2.71
Continuity of care in general practice: a review and critique. Fam Pract (1984) 2.56
Disruption of c-mos causes parthenogenetic development of unfertilized mouse eggs. Nature (1994) 2.54
Fate of teratocarcinoma cells injected into early mouse embryos. Nature (1975) 2.48
Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data. J Clin Oncol (2000) 2.46
Ineffectiveness of AIDS education and HIV antibody testing in reducing high-risk behaviors among injection drug users. Am J Public Health (1992) 2.43
Role of the Clara cell in renewal of the bronchiolar epithelium. Lab Invest (1978) 2.42
Stage-specific embryonic antigen involves alpha 1 goes to 3 fucosylated type 2 blood group chains. Nature (1981) 2.35
A potential animal model for Lesch-Nyhan syndrome through introduction of HPRT mutations into mice. Nature (1987) 2.33
Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer--a randomized trial with quality of life as the primary outcome. UK NSCLC Gemcitabine Group. Non-Small Cell Lung Cancer. Br J Cancer (2000) 2.30
Salmonella typhi uses CFTR to enter intestinal epithelial cells. Nature (1998) 2.29
Local bone mineral response to brief exercise that stresses the skeleton. BMJ (1989) 2.25
The London Academic Training Scheme (LATS): an evaluation. Fam Pract (1998) 2.23
Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life. Thorax (2004) 2.22
Sales of nonprescription cold remedies: a unique method of influenza surveillance. Pediatr Res (1979) 2.22
The murine H19 gene is activated during embryonic stem cell differentiation in vitro and at the time of implantation in the developing embryo. Development (1991) 2.17
Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial. Eur J Cardiothorac Surg (2004) 2.14
Cloning of Ly-5 cDNA. Proc Natl Acad Sci U S A (1985) 2.12
Assessment of quality of life in the supportive care setting of the big lung trial in non-small-cell lung cancer. J Clin Oncol (2005) 2.04
Effect of 2',3'-dideoxythymidine-5'-triphosphate on HeLa cell in vitro DNA synthesis: evidence that DNA polymerase alpha is the only polymerase required for cellular DNA replication. Nucleic Acids Res (1978) 2.04
Mendelian randomization and estimation of treatment efficacy for chronic diseases. Am J Epidemiol (2013) 2.01
Comparison of survival, palliation, and quality of life with three chemotherapy regimens in metastatic colorectal cancer: a multicentre randomised trial. Lancet (2002) 2.00
The isolation and properties of a clonal tissue culture strain of pluripotent mouse teratoma cells. J Embryol Exp Morphol (1972) 1.96
Generation and characterization of a delta F508 cystic fibrosis mouse model. Nat Genet (1995) 1.96
Pressure waves in so-called low-pressure hydrocephalus. Lancet (1972) 1.94
Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status. Medical Research Council Lung Cancer Working Party. Clin Oncol (R Coll Radiol) (1996) 1.93
Detection of group C rotavirus in infants with extrahepatic biliary atresia. J Infect Dis (1996) 1.91
Squaring the circle? Br J Gen Pract (1991) 1.91
Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disrupted endochondral ossification and mild osteopetrosis. Development (1996) 1.88
Renewal of the terminal bronchiolar epithelium in the rat following exposure to NO2 or O3. Lab Invest (1976) 1.85
Mice deficient for the secreted glycoprotein SPARC/osteonectin/BM40 develop normally but show severe age-onset cataract formation and disruption of the lens. EMBO J (1998) 1.83
Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-1 antibodies. Transplantation (1995) 1.82
Separation of Newcastle disease virus proteins by polyacrylamide gel electrophoresis. Virology (1969) 1.80
Production of a severe cystic fibrosis mutation in mice by gene targeting. Nat Genet (1993) 1.80
Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy. Nature (1993) 1.79
Evidence of a locus for orofacial clefting on human chromosome 6p24 and STS content map of the region. Hum Mol Genet (1995) 1.75
Antibiotic prophylaxis in total hip replacement. Br Med J (1979) 1.73
Following cell fate in the living mouse embryo. Development (1997) 1.72
Isolated human follicular dendritic cells display a unique antigenic phenotype. J Exp Med (1989) 1.72
Role of nonciliated cells in renewal of the bronchial epithelium of rats exposed to NO2. Am J Pathol (1986) 1.71
Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv. Mol Immunol (1996) 1.67
The use of the laryngeal mask in surgical tracheostomy. Br J Oral Maxillofac Surg (2005) 1.61
Differential up-regulation of the B7-1 and B7-2 costimulatory molecules after Ig receptor engagement by antigen. J Immunol (1994) 1.61
Effects of 2',3'-dideoxynucleosides on mammalian cells and viruses. J Cell Physiol (1984) 1.57
Inflammation in cystic fibrosis airways: relationship to increased bacterial adherence. Eur Respir J (2001) 1.55
Mitotic checkpoint inactivation fosters transformation in cells lacking the breast cancer susceptibility gene, Brca2. Mol Cell (1999) 1.53
Comparison of intermittent and continuous palliative chemotherapy for advanced colorectal cancer: a multicentre randomised trial. Lancet (2003) 1.52
Symptoms at presentation for treatment in patients with lung cancer: implications for the evaluation of palliative treatment. The Medical Research Council (MRC) Lung Cancer Working Party. Br J Cancer (1995) 1.52
A review of the biological properties and metabolic disposition of the new analgesic agent, meptazinol. Gen Pharmacol (1978) 1.47
Retinal toxicity due to Efavirenz. Eye (Lond) (2001) 1.46
The Hox11 gene is essential for cell survival during spleen development. Development (1995) 1.45
Early response of lungs to low levels of nitrogen dioxide. Light and electron microscopy. Arch Environ Health (1972) 1.44
The antinociceptive activity of meptazinol depends on both opiate and cholinergic mechanisms. Br J Pharmacol (1983) 1.44
Identification of cells labeled with tritiated thymidine in the pulmonary alveolar walls of the mouse. Am Rev Respir Dis (1969) 1.43
Mos is required for MAP kinase activation and is involved in microtubule organization during meiotic maturation in the mouse. Development (1996) 1.40
Construction and implantation of a cannula system for repeated injections into localized regions of the rat brain. J Pharm Pharmacol (1975) 1.39
Thirty years of Medical Research Council randomized trials in solid tumours. Clin Oncol (R Coll Radiol) (1997) 1.38
Psychomotor performance: the effects of continuous noise and augmented feedback. Appl Ergon (1978) 1.38
GPs' differing responses to out-of-hours calls. Practitioner (1989) 1.37
Establishment of pluripotential cell lines from haploid mouse embryos. J Embryol Exp Morphol (1983) 1.36
Changes in the expression and polarization of blood group I and i antigens in post-implantation embryos and teratocarcinomas of mouse associated with cell differentiation. Exp Cell Res (1981) 1.36
Biochemical markers of the progress of differentiation in cloned teratocarcinoma cell lines. Eur J Biochem (1977) 1.36
Thymic lymphomas in mice with a truncating mutation in Brca2. Cancer Res (1998) 1.36
Measles virus haemagglutinin gene: cloning, complete nucleotide sequence analysis and expression in COS cells. J Gen Virol (1986) 1.33
Interventions among primary-care practitioners to improve care for preventable complications of diabetes. Diabetes Care (1988) 1.32
Hemoglobin messenger ribonucleic acid. Distribution of the 9S ribonucleic acid in polysomes of different sizes. Biochemistry (1969) 1.32
Ultrastructural changes in cells of the mouse footpad infected with Mycobacterium leprae. Infect Immun (1972) 1.31
Studies of case-finding for pulmonary tuberculosis in outpatients at 4 district hospitals in Kenya. Tubercle (1985) 1.31
X-chromosome instability in pluripotential stem cell lines derived from parthenogenetic embryos. J Embryol Exp Morphol (1983) 1.30
An indelible lineage marker for Xenopus using a mutated green fluorescent protein. Development (1996) 1.30
The morphology and growth of a pluripotent teratocarcinoma cell line and its derivatives in tissue culture. Cell (1974) 1.28
5-year follow-up of cytotoxic chemotherapy as an adjuvant to surgery in carcinoma of the bronchus. Br J Cancer (1976) 1.27
Assessment of quality of life in small-cell lung cancer using a Daily Diary Card developed by the Medical Research Council Lung Cancer Working Party. Br J Cancer (1991) 1.26